Bernard M Branson1, Pollyanna R Chavez1, Brett Hanscom2, Elizabeth Greene3, Laura McKinstry2, Kate Buchacz1, Geetha Beauchamp2, Theresa Gamble2, Barry S Zingman4, Edward Telzak5, Tammey Naab6, Lisa Fitzpatrick7, Wafaa M El-Sadr8. 1. Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington. 3. Leadership and Operations Center, HIV Prevention Trials Network, FHI, Durham, North Carolina. 4. Montefiore Medical Center and Albert Einstein College of Medicine, Bronx. 5. Bronx Lebanon Hospital Center, New York. 6. Howard University Hospital, Washington, District of Columbia. 7. United Medical Center, Washington, District of Columbia. 8. ICAP at Columbia University, New York, New York.
Abstract
Background: Human immunodeficiency virus (HIV) testing is critical for both HIV treatment and prevention. Expanding testing in hospital settings can identify undiagnosed HIV infections. Methods: To evaluate the feasibility of universally offering HIV testing during emergency department (ED) visits and inpatient admissions, 9 hospitals in the Bronx, New York and 7 in Washington, District of Columbia (DC) undertook efforts to offer HIV testing routinely. Outcomes included the percentage of encounters with an HIV test, the change from year 1 to year 3, and the percentages of tests that were HIV-positive and new diagnoses. Results: From 1 February 2011 to 31 January 2014, HIV tests were conducted during 6.5% of 1621016 ED visits and 13.0% of 361745 inpatient admissions in Bronx hospitals and 13.8% of 729172 ED visits and 22.0% of 150655 inpatient admissions in DC. From year 1 to year 3, testing was stable in the Bronx (ED visits: 6.6% to 6.9%; inpatient admissions: 13.0% to 13.6%), but increased in DC (ED visits: 11.9% to 15.8%; inpatient admissions: 19.0% to 23.9%). In the Bronx, 0.4% (408) of ED HIV tests were positive and 0.3% (277) were new diagnoses; 1.8% (828) of inpatient tests were positive and 0.5% (244) were new diagnoses. In DC, 0.6% (618) of ED tests were positive and 0.4% (404) were new diagnoses; 4.9% (1349) of inpatient tests were positive and 0.7% (189) were new diagnoses. Conclusions: Hospitals consistently identified previously undiagnosed HIV infections, but universal offer of HIV testing proved elusive.
Background: Human immunodeficiency virus (HIV) testing is critical for both HIV treatment and prevention. Expanding testing in hospital settings can identify undiagnosed HIV infections. Methods: To evaluate the feasibility of universally offering HIV testing during emergency department (ED) visits and inpatient admissions, 9 hospitals in the Bronx, New York and 7 in Washington, District of Columbia (DC) undertook efforts to offer HIV testing routinely. Outcomes included the percentage of encounters with an HIV test, the change from year 1 to year 3, and the percentages of tests that were HIV-positive and new diagnoses. Results: From 1 February 2011 to 31 January 2014, HIV tests were conducted during 6.5% of 1621016 ED visits and 13.0% of 361745 inpatient admissions in Bronx hospitals and 13.8% of 729172 ED visits and 22.0% of 150655 inpatient admissions in DC. From year 1 to year 3, testing was stable in the Bronx (ED visits: 6.6% to 6.9%; inpatient admissions: 13.0% to 13.6%), but increased in DC (ED visits: 11.9% to 15.8%; inpatient admissions: 19.0% to 23.9%). In the Bronx, 0.4% (408) of ED HIV tests were positive and 0.3% (277) were new diagnoses; 1.8% (828) of inpatient tests were positive and 0.5% (244) were new diagnoses. In DC, 0.6% (618) of ED tests were positive and 0.4% (404) were new diagnoses; 4.9% (1349) of inpatient tests were positive and 0.7% (189) were new diagnoses. Conclusions: Hospitals consistently identified previously undiagnosed HIV infections, but universal offer of HIV testing proved elusive.
Authors: Nathan J Hudepohl; Christopher J Lindsell; Kimberly W Hart; Andrew H Ruffner; Alexander T Trott; Carl J Fichtenbaum; Michael S Lyons Journal: Ann Emerg Med Date: 2011-07 Impact factor: 5.721
Authors: Jamie L Mignano; Lucy Miner; Kristin Siedl; Travis Brown; Christina Cafeo; Lisa Rowen; Robert R Redfield; Mangla Gulati Journal: Popul Health Manag Date: 2017-06-13 Impact factor: 2.459
Authors: Jeffrey L Greenwald; Catherine A Rich; Samantha Bessega; Michael A Posner; Jared Lane Maeda; Paul R Skolnik Journal: Mayo Clin Proc Date: 2006-04 Impact factor: 7.616
Authors: Matthew Bidwell Goetz; Tuyen Hoang; Herschel Knapp; Jane Burgess; Michael D Fletcher; Allen L Gifford; Steven M Asch Journal: J Gen Intern Med Date: 2013-04-19 Impact factor: 5.128
Authors: Theresa Gamble; Bernard Branson; Deborah Donnell; H Irene Hall; Georgette King; Blayne Cutler; Shannon Hader; David Burns; Jason Leider; Angela Fulwood Wood; Kevin G Volpp; Kate Buchacz; Wafaa M El-Sadr Journal: Clin Trials Date: 2017-06-19 Impact factor: 2.486